.svg)
A protocol amendment hits mid-study. Enrollment is trending ahead of projections at a cluster of sites. Supply pressure is building in a region where inbound shipments take three weeks.
The data that could inform every one of those decisions already exists inside your RTSM. The question is whether your team can access it before the window closes.
That gap — between data that exists and decisions that need to happen — is where modern trials lose ground.
RTSM was built to record activity. Modern trials depend on decision speed.
In today’s operating environment, the greatest risk is not data quality. It is latency. When insight arrives too late, even accurate data loses operational value.
As trials become more adaptive, more global, and more complex, success depends on whether teams can understand what is happening while execution is still underway. This shift is forcing a fundamental rethink of what RTSM is expected to deliver.
________________
The legacy model: RTSM as a rearview mirror
Traditional RTSM reporting follows a familiar pattern:
Even when this process works exactly as designed, insight arrives after the fact. Data is analyzed downstream from execution — separate from the decisions it is meant to inform.
That gap is no longer acceptable.
Modern trials require decisions to happen in motion, using live operational data. Waiting on exports, reconciliations, or specialized intervention slows execution and increases risk. Intelligence can no longer sit outside RTSM. It must exist within the workflows where decisions are made.
________________
What real-time intelligence actually means
Real-time intelligence is often misunderstood.
It is not more dashboards. It is not faster exports. It is not another reporting layer applied after execution.
Real-time intelligence changes how teams interact with data during a live study.
In practice, it means:
Insight is no longer something teams step away to generate. It becomes part of execution itself.
________________
eloAI: Asking questions of live trial data and getting answers
What makes this possible is not just access to data — it is confidence in the data being interrogated.
Elosity’s data foundation is built to ensure that what eloAI surfaces reflects the current, governed state of the study, not a snapshot from last week. Study logic, supply activity, and operational changes remain controlled and auditable even as studies evolve, so fast answers are also trustworthy ones.
eloAI is an intelligent data companion embedded directly into Elosity. It allows teams to ask questions of live RTSM and supply data using natural language and receive immediate, contextual answers while preserving blinding, role-based access, and regulatory integrity.
________________
A clinical operations manager notices enrollment trending above projections. Rather than submitting a report request, she types directly into Elosity:
“Which sites in Region 3 have randomized more than 15 patients in the last 14 days, and what is their current projected kit demand for the next 30 days?”
Within seconds, she has a governed, role-appropriate answer drawn from live RTSM data — no export, no intermediary, no wait. She has what she needs to make a decision before the window closes.
Instead of requesting reports or exporting datasets, teams can:
Data remains governed, secure, and in context. Insight arrives at the moment decisions matter.
This is not faster reporting. It is a fundamentally different way of working with trial data.
________________
Elosity Insights: Visibility that scales across programs
Real-time interaction handles the moment. But not every operational question happens in real time. Some patterns only emerge across studies, over time, and at scale.
Elosity Insights provides a modern reporting platform designed to support repeatable visibility across inventory, patient, and supply domains. Standardized reporting spans global and site-level inventory, serialized kit status, shipments, dosing activity, visits, and projected demand.
Built on an event-driven architecture, Elosity Insights captures changes as they occur and processes them through a cloud-native platform. This reduces reliance on one-off exports and custom builds while creating a durable path from RTSM execution to operational reporting.
For organizations managing multiple studies, this means reporting that scales with complexity instead of adding operational overhead with each new protocol.
________________
Why this matters now
Trial execution is evolving faster than traditional reporting cycles can support. Protocol amendments, enrollment variability, supply pressure, and global execution all require faster understanding, not more static reports.
eloAI and Elosity Insights work together to close the gap between data availability and decision-making. RTSM evolves from a system of record into a system of insight where execution, intelligence, and oversight operate as one.
Reducing wait time reduces risk.
The future of RTSM is not defined by more reports.
It is defined by fewer delays between question and action.
Because in modern trials, the risk is not lacking data.
It is waiting too long to understand it.
________________
Stop waiting on reports. See what real-time intelligence looks like inside a live Elosity study, including a guided walkthrough of eloAI and Elosity Insights interacting with live trial data.
Request a live demo:
endpointclinical.com/solutions-elosity
Why RTSM Needs Real-Time Intelligence
How Elosity enables shared inventory across protocols, reducing waste and preventing stockouts.
Meet eloAI - Your intelligent data companion inside Elosity.
